Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1741

1.

Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.

Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E; PEACE Investigators.

Circulation. 2007 Mar 27;115(12):1528-36. Epub 2007 Mar 19.

2.

Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.

Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.

Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):144-50. doi: 10.1016/j.carrev.2009.01.005.

PMID:
19595394
3.

Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.

Sabatine MS, Morrow DA, O'Donoghue M, Jablonksi KA, Rice MM, Solomon S, Rosenberg Y, Domanski MJ, Hsia J; PEACE Investigators.

Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2463-9. Epub 2007 Aug 31.

4.

Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.

Dosh K, Berger PB, Marso S, van Lente F, Brennan DM, Charnigo R, Topol EJ, Steinhubl S.

Circ Cardiovasc Interv. 2009 Dec;2(6):503-12. doi: 10.1161/CIRCINTERVENTIONS.109.879312. Epub 2009 Nov 17.

5.

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E; PEACE Investigators.

J Am Coll Cardiol. 2007 Jul 17;50(3):205-14. Epub 2007 Jun 29.

6.

Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: a prospective observational study.

Balciunas M, Bagdonaite L, Samalavicius R, Griskevicius L, Vuylsteke A.

Ann Card Anaesth. 2009 Jul-Dec;12(2):127-32. doi: 10.4103/0971-9784.53442.

7.

Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis.

Schillinger M, Exner M, Amighi J, Mlekusch W, Sabeti S, Rumpold H, Wagner O, Minar E.

Circulation. 2003 Nov 11;108(19):2323-8. Epub 2003 Oct 13.

8.

Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?

Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF, Li PK, Sanderson J.

J Am Soc Nephrol. 2003 Jul;14(7):1871-9.

9.

Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.

Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB; Intermountain Heart Collaborative (IHC) Study Group.

Am J Cardiol. 2002 Jan 15;89(2):145-9.

PMID:
11792332
10.

[Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?].

Kiliç T, Ural E, Oner G, Sahin T, Kiliç M, Yavuz S, Kanko M, Kahraman G, Bildirici U, Berki KT, Ural D.

Anadolu Kardiyol Derg. 2009 Aug;9(4):280-9. Turkish.

11.

Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.

Gach O, Legrand V, Biessaux Y, Chapelle JP, Vanbelle S, Pierard LA.

Am J Cardiol. 2007 Jan 1;99(1):31-5. Epub 2006 Nov 9.

12.

Elevated serum C-reactive protein levels predict cardiovascular events in the Japanese coronary artery disease (JCAD) study.

Shimada K, Fujita M, Tanaka A, Yoshida K, Jisso S, Tanaka H, Yoshikawa J, Kohro T, Hayashi D, Okada Y, Yamazaki T, Nagai R; JCAD Investigators.

Circ J. 2009 Jan;73(1):78-85. Epub 2008 Nov 17.

13.

Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.

Roman RM, Camargo PV, Borges FK, Rossini AP, Polanczyk CA.

Coron Artery Dis. 2010 May;21(3):129-36. doi: 10.1097/MCA.0b013e328333f50d.

PMID:
20305551
14.

[Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].

Huang W, Chen QW, Lei H, Deng W, Ke DZ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Aug;34(8):718-21. Chinese.

PMID:
17081398
15.

C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.

Razzouk L, Muntner P, Bansilal S, Kini AS, Aneja A, Mozes J, Ivan O, Jakkula M, Sharma S, Farkouh ME.

Am Heart J. 2009 Aug;158(2):277-83. doi: 10.1016/j.ahj.2009.05.026.

PMID:
19619706
16.

Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease.

Aguilar D, Fisher MR, O'Connor CM, Dunne MW, Muhlestein JB, Yao L, Gupta S, Benner RJ, Cook TD, Edwards D, Pfeffer MA; Investigators in the Weekly Intervention with Zithromax for Atherosclerosis and its Related Disorder study.

Am Heart J. 2006 Aug;152(2):298-304.

PMID:
16875914
17.

Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.

Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate RJ, Kutcher MA, Sane DC.

Am Heart J. 2008 Aug;156(2):234-40. doi: 10.1016/j.ahj.2008.03.015. Epub 2008 May 14.

PMID:
18657651
19.

The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.

Anand DV, Lahiri A, Lim E, Hopkins D, Corder R.

J Am Coll Cardiol. 2006 May 2;47(9):1850-7. Epub 2006 Apr 19.

20.

Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.

van der Harst P, Voors AA, Volbeda M, Buikema H, van Veldhuisen DJ, van Gilst WH.

Am J Cardiol. 2006 Jun 15;97(12):1697-701. Epub 2006 Apr 21.

PMID:
16765116

Supplemental Content

Support Center